Literature DB >> 31422505

Anti-MuSK ocular myasthenia with extrinsic ocular muscle atrophy: a new clinical phenotype?

Dario Ricciardi1, Vincenzo Todisco1, Gioacchino Tedeschi1, Giovanni Cirillo2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31422505     DOI： 10.1007/s10072-019-04038-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  11 in total

1.  Is tongue atrophy reversible in anti-MuSK myasthenia gravis? Six-year observation.

Authors:  Hirokatsu Takahashi; Naoki Kawaguchi; Shoichi Ito; Yuko Nemoto; Takamichi Hattori; Satoshi Kuwabara
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06       Impact factor: 10.154

2.  MuSK-antibody positive pure ocular myasthenia gravis.

Authors:  Frank Hanisch; Katharina Eger; Stephan Zierz
Journal:  J Neurol       Date:  2005-11-29       Impact factor: 4.849

3.  Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy.

Authors:  Jane W Chan; William W Orrison
Journal:  Br J Ophthalmol       Date:  2007-06       Impact factor: 4.638

4.  Anti-MuSK antibodies in a case of ocular myasthenia gravis.

Authors:  D L H Bennett; K R Mills; P Riordan-Eva; P R J Barnes; M R Rose
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

5.  Antibody profile may predict outcome in ocular myasthenia gravis.

Authors:  Giuliana Galassi; Marco Mazzoli; Alessandra Ariatti; Shaniko Kaleci; Franco Valzania; Paolo F Nichelli
Journal:  Acta Neurol Belg       Date:  2018-06-01       Impact factor: 2.396

6.  Pure ocular anti-musk myasthenia under no immunosuppressive treatment.

Authors:  Vasiliki Zouvelou; Athanasios Papathanasiou; Christos Koros; Michael Rentzos; Thomas Zambelis; Eleftherios Stamboulis
Journal:  Muscle Nerve       Date:  2013-07-27       Impact factor: 3.217

7.  Anti-MuSK myasthenia gravis presenting with purely ocular findings.

Authors:  James B Caress; Christopher H Hunt; Sat Dev Batish
Journal:  Arch Neurol       Date:  2005-06

Review 8.  Myasthenia gravis: subgroup classification and therapeutic strategies.

Authors:  Nils Erik Gilhus; Jan J Verschuuren
Journal:  Lancet Neurol       Date:  2015-10       Impact factor: 44.182

9.  Pattern of ocular involvement in myasthenia gravis with MuSK antibodies.

Authors:  Amelia Evoli; Paolo E Alboini; Raffaele Iorio; Valentina Damato; Emanuela Bartoccioni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-06-10       Impact factor: 10.154

Review 10.  An ocular form of myasthenia gravis with a high titer of anti-MuSK antibodies during a long-term follow-up.

Authors:  Ai Hosaka; Hiroshi Takuma; Kiyoe Ohta; Akira Tamaoka
Journal:  Intern Med       Date:  2012-11-01       Impact factor: 1.271
View more
  2 in total

1.  MRI evidence of extraocular muscle atrophy and fatty replacement in myasthenia gravis.

Authors:  Georgios Velonakis; Vassilis E Papadopoulos; Efstratios Karavasilis; Dimitrios K Filippiadis; Vasiliki Zouvelou
Journal:  Neuroradiology       Date:  2021-07-07       Impact factor: 2.804

2.  Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study.

Authors:  Sijia Zhao; Kai Zhang; Kaixi Ren; Jiarui Lu; Chao Ma; Cong Zhao; Zhuyi Li; Jun Guo
Journal:  BMC Neurol       Date:  2021-11-04       Impact factor: 2.474
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.